Governance evidence
What agencies reported about the OMB M-25-21 minimum practices for high-impact AI. This is a disclosure analysis, not an audit, a compliance finding or an official assessment. An unanswered question is missing evidence, not evidence that a safeguard is absent.
Practice-by-practice evidence
Denominator: 6 records · all use cases in the current filterReported in progress: 1 (16.7%)Pre-deployment testing
No answer reported: 5 (83.3%)
| Practice | In scope | In place | In progress | Not in place | N/A | Precluded or waived | Other | No answer | Answered | In place of applicable |
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-deployment testing | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 5 | 17% | 0% of 6 |
| AI impact assessment | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 5 | 17% | 0% of 6 |
| Independent review | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0% | 0% of 6 |
| Ongoing monitoring | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0% | 0% of 6 |
| Operator training | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0% | 0% of 6 |
| Fail-safe | 6 | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 17% | 0% of 5 |
| Appeal process | 6 | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 17% | 0% of 5 |
| User and public consultation | 6 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 17% | 0% of 6 |
Answered = records with any answer ÷ records in scope. In place of applicable = reported in place ÷ (in scope minus not applicable, precluded and waived). Unanswered records stay in that denominator, so the rate is a lower bound on reported evidence, not an estimate of real practice.
| Testing | Impact assess. | Indep. review | Monitoring | Training | Fail-safe | Appeal | Consultation | n | |
|---|---|---|---|---|---|---|---|---|---|
| HHS | – | – | – | – | – | – | – | – | 3 |
| USDA | – | – | – | – | – | – | – | – | 1 |
| DOJ | – | – | – | – | – | – | – | – | 1 |
| DOE | 0% | 0% | – | – | – | 0% | 0% | 0% | 1 |
Hatched cells: the agency answered nothing for that practice, so there is no evidence either way. Compare agencies with care: each agency is one reporting unit, and portfolios differ in size and type.
Records requiring further investigation
6 records with at least one practice unanswered or in progressOpen in explorer| Use case | Stage | Test | AIA | Review | Monitor | Train | Fail-safe | Appeal | Consult |
|---|---|---|---|---|---|---|---|---|---|
| LISA Chatbot Pilot DOE · DOE-671 | Pilot | Reported in progress | Reported in progress | No answer reported | No answer reported | No answer reported | Not applicable | Not applicable | Other or ambiguous answer |
| Voicemail Transcription, Translation and Summarization DOJ · DOJ-0243 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| Medicare AI Customer Insights HHS · R0783 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| Medicare AI Drug Search HHS · R0784 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| AWS Exscribo HHS · R0999 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
| FSA FLP Chatbot USDA · USDA-052 | Pilot | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported | No answer reported |
Unanswered analytical questions
Generated from the data; for follow-up with agencies- 1 high-impact use cases report using PII but give no link to a Privacy Impact Assessment. Is a PIA published elsewhere?
These are questions the inventory raises but cannot answer. They are not findings of non-compliance.